249 related articles for article (PubMed ID: 17287256)
1. Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells.
Di Piazza M; Mader C; Geletneky K; Herrero Y Calle M; Weber E; Schlehofer J; Deleu L; Rommelaere J
J Virol; 2007 Apr; 81(8):4186-98. PubMed ID: 17287256
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic implications of the enhanced short and long-term cytotoxicity of radiation treatment followed by oncolytic parvovirus H-1 infection in high-grade glioma cells.
Geletneky K; Hartkopf AD; Krempien R; Rommelaere J; Schlehofer JR
Bioeng Bugs; 2010; 1(6):429-33. PubMed ID: 21468212
[TBL] [Abstract][Full Text] [Related]
3. Regression of glioma in rat models by intranasal application of parvovirus h-1.
Kiprianova I; Thomas N; Ayache A; Fischer M; Leuchs B; Klein M; Rommelaere J; Schlehofer JR
Clin Cancer Res; 2011 Aug; 17(16):5333-42. PubMed ID: 21715567
[TBL] [Abstract][Full Text] [Related]
4. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
Trinkaus M; Vranic A; Dolenc VV; Lah TT
Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
[TBL] [Abstract][Full Text] [Related]
5. Alterations of cathepsins B, H and L in proximal tubules from polycystic kidneys of the Han:SPRD rat.
Schaefer L; Han X; Gretz N; Schaefer RM
Kidney Int; 1996 Aug; 50(2):424-31. PubMed ID: 8840269
[TBL] [Abstract][Full Text] [Related]
6. Cysteine cathepsins are not critical for TRAIL- and CD95-induced apoptosis in several human cancer cell lines.
Špes A; Sobotic B; Turk V; Turk B
Biol Chem; 2012 Dec; 393(12):1417-31. PubMed ID: 23667901
[TBL] [Abstract][Full Text] [Related]
7. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
Colella R; Casey SF
Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
[TBL] [Abstract][Full Text] [Related]
8. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
[TBL] [Abstract][Full Text] [Related]
9. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
Mason RW; Sol-Church K; Abrahamson M
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
[TBL] [Abstract][Full Text] [Related]
10. Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.
Geletneky K; Kiprianova I; Ayache A; Koch R; Herrero Y Calle M; Deleu L; Sommer C; Thomas N; Rommelaere J; Schlehofer JR
Neuro Oncol; 2010 Aug; 12(8):804-14. PubMed ID: 20299703
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin-dependent apoptosis triggered by supraoptimal activation of T lymphocytes: a possible mechanism of high dose tolerance.
Michallet MC; Saltel F; Flacher M; Revillard JP; Genestier L
J Immunol; 2004 May; 172(9):5405-14. PubMed ID: 15100281
[TBL] [Abstract][Full Text] [Related]
12. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
[TBL] [Abstract][Full Text] [Related]
13. Expression and the role of cathepsin H in human glioma progression and invasion.
Sivaparvathi M; Sawaya R; Gokaslan ZL; Chintala SK; Rao JS
Cancer Lett; 1996 Jun; 104(1):121-6. PubMed ID: 8640738
[TBL] [Abstract][Full Text] [Related]
14. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing.
Dahl SW; Halkier T; Lauritzen C; Dolenc I; Pedersen J; Turk V; Turk B
Biochemistry; 2001 Feb; 40(6):1671-8. PubMed ID: 11327826
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal cysteine proteinases in rat epididymis.
Tomomasa H; Waguri S; Umeda T; Koiso K; Kominami E; Uchiyama Y
J Histochem Cytochem; 1994 Mar; 42(3):417-25. PubMed ID: 8308258
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia inhibits TRAIL-induced tumor cell apoptosis: involvement of lysosomal cathepsins.
Nagaraj NS; Vigneswaran N; Zacharias W
Apoptosis; 2007 Jan; 12(1):125-39. PubMed ID: 17136492
[TBL] [Abstract][Full Text] [Related]
17. Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells.
Knight MJ; Riffkin CD; Muscat AM; Ashley DM; Hawkins CJ
Oncogene; 2001 Sep; 20(41):5789-98. PubMed ID: 11593384
[TBL] [Abstract][Full Text] [Related]
18. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress.
Kågedal K; Johansson U; Ollinger K
FASEB J; 2001 Jul; 15(9):1592-4. PubMed ID: 11427496
[No Abstract] [Full Text] [Related]
19. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L.
Fröhlich E; Möhrle M; Klessen C
Arch Dermatol Res; 2004 Mar; 295(10):411-21. PubMed ID: 14767779
[TBL] [Abstract][Full Text] [Related]
20. Expression of cysteine proteinases and their inhibitor, cystatin beta, in cultured rat mesangial cells.
Makita Y; Ishidoh K; Kominami E; Funabiki K; Koide H; Tomino Y
J Diabetes Complications; 1998; 12(6):328-36. PubMed ID: 9877467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]